Daniel Olive

This paper shows that blocking PVR and Nectin-2 reactivates macrophage anti-tumor functions and reduces cervical tumor growth in pre-clinical models.

This study develops N4CART cells targeting Nectin-4 that overcome resistance to EV in solid tumors and show safety by avoiding skin toxicity.

This study shows that tertiary lymphoid structures in cervical cancer are linked to immune activation and better patient outcomes.